NHE-1: A Promising Target for Novel Anti-cancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|10|1372-1382

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.10, 2012-04, pp. : 1372-1382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 5, Iss. 3, 2005-05 ,pp. : 149-157

Bentham Science Publishers

Access to resources Recommend Favorite

Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 404-422

Bentham Science Publishers

Access to resources Recommend Favorite

Plasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial Chemotherapy

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-06 ,pp. : 226-239

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria: A Promising Target for Anticancer Alkaloids

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 17, 2013-01 ,pp. : 2171-2183

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3201-3209

Bentham Science Publishers

Access to resources Recommend Favorite